HOME >> BIOLOGY >> NEWS
SARS pre-screening protocol developed for AACR Annual Meeting in Washington, D.C.

To provide an additional line of defense against the spread of SARS, the American Association for Cancer Research (AACR) has entered into an agreement with International SOS to pre-screen registrants and exhibitors from SARS-affected areas attending its upcoming Annual Meeting in Washington, D.C.

International SOS, the world's largest medical and security assistance company, will be pre-screening all attendees from SARS-affected nations prior to their travel to the meeting. AACR, with SOS, has created a protocol, based on guidelines from the U.S. Centers for Disease Control (CDC), that will identify individuals from affected areas who may have been exposed to SARS patients or who themselves are experiencing symptoms characteristic of the respiratory illness.

The protocol will take the form of a questionnaire that will assess the health of these individuals to determine if they are asymptomatic and able to attend the meeting. Attendees will be able to speak to SOS medical staff in their local language if required.

"We at the AACR place a premium on the safety of those attending our meetings, including those registrants who care for immune-compromised patients with cancer," said Margaret Foti, Ph.D., AACR chief executive officer. "This protocol, developed by AACR with International SOS - a leader in the field of global medical services -- will give us added protection at our Annual Meeting."

In early April, the AACR was forced to cancel its Annual Meeting in Toronto, Canada, as a result of the SARS outbreak in that city. The meeting, with an expected attendance of 16,000 people, was subsequently rescheduled for July 11-14, 2003, in the new, state-of-the-art Washington Convention Center in Washington, D.C.

SOS will be providing a toll-free number for attendees to obtain medical advice about SARS. Their website, www.internationalsos.com, also contains the latest information about the
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
30-May-2003


Page: 1 2

Related biology news :

1. Re-creating the ocean, Temple prof. developing protocols for using oil dispersants
2. Standardized treatment protocol reduces deaths from malnutrition by 47%
3. Computer database being developed at Temple will allow for better inventory of chemicals
4. New software developed at Rensselaer predicts promising ingredients for new drugs
5. New imaging technique developed to identify breast cancer
6. Portable kidney dialysis machine developed
7. New method of identifying and isolating stem cells developed
8. Study calls for cheaper antitoxins for plant poisoning in less-developed countries
9. Fe-TAML(R) activators developed at Carnegie Mellon remove recalcitrant sulfur from automotive fuels
10. Fe-TAML(R) activators developed at Carnegie Mellon decontaminate anthrax simulant
11. Fe-TAML(R) activators developed at Carnegie Mellon break down toxic pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... June 18, 2020 , ... Join experts from Envigo ... in a live webinar on Wednesday, July 8, 2020 at 11am EDT ... we genetically engineer new models. However, while modifying the genome may be more straightforward, ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. ... automation and IT solutions for the life sciences industry, is pleased to announce the ... working out of the company’s Seabrook, New Hampshire office. In his new role, ...
(Date:6/5/2020)... ... ... Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, welcomes ... a global perspective to make an impact in a post pandemic world,” said Co-Chairman ... independent, director of the company. , “The Greffex board is excited to have Neil ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... insights, today announced that the launch of a new clinical diagnostics ... about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... develop a vaccine or drug treatment. In an effort to better understand the ... released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 ...
(Date:6/28/2020)... , ... June 26, 2020 , ... ... representing security solutions providers, today announced its strong opposition to the recently introduced ... would impose a blanket ban on most federal use of nearly all biometric ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
Breaking Biology Technology:
Cached News: